Drugs industry urged to develop medicines for childrenBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7337.563/a (Published 09 March 2002) Cite this as: BMJ 2002;324:563
- Rory Watson
The European Commission is urging the pharmaceutical industry to develop medicines that are especially suitable for children.
The initiative is designed to remedy the situation whereby 50-90% of medicinal products given to people aged under 16 years have never been specifically evaluated for use in children.
In a new consultation paper, the commission maintains that the absence of specific paediatric formulations may cause problems for Europe's 80 million younger patients when trying to swallow tablets and could lead to serious calculation errors when adult dosages are adjusted for the treatment of …
Log in using your username and password
Log in through your institution
Sign up for a free trial